Literature DB >> 10510164

Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors.

P März1, U Otten, S Rose-John.   

Abstract

Cytokines of the interleukin-6 (IL-6) family participate in regulatory and inflammatory processes within the nervous system. IL-6, ciliary neurotrophic factor (CNTF) and IL-11 act via specific membrane receptors which, together with their ligands, associate with signal-transducing receptor subunits thereby initiating cytoplasmic signalling. Cells which only express signal-transducing receptor subunits but no ligand binding subunits for IL-6, CNTF and IL-11 are refractory to these cytokines. An unusual feature of the IL-6 cytokine family is that the soluble forms of the ligand binding receptor subunits generated by one cell type in complex with their ligands can directly stimulate the signal-transducing receptor subunits on different cell types which lack ligand binding receptor subunits. This process has been named transsignalling. This article focuses on the importance of transsignalling events in neuronal differentiation and survival responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510164     DOI: 10.1046/j.1460-9568.1999.00755.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  33 in total

1.  Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin.

Authors:  A Oprée; M Kress
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

3.  Intrapituitary cytokines in Cushing's disease: do they play a role?

Authors:  Agostino Paoletta; Giorgio Arnaldi; Roberta Papa; Marco Boscaro; Giacomo Tirabassi
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

Review 4.  Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.

Authors:  Heike Knüpfer; Rainer Preiss
Journal:  Breast Care (Basel)       Date:  2010-06       Impact factor: 2.860

5.  Association of Variants in IL6-Related Genes with Lung Cancer Risk in Moroccan Population.

Authors:  Houda Kaanane; Nezha Senhaji; Hind Berradi; Nadia Benchakroun; Abdellatif Benider; Mehdi Karkouri; Hicham El Attar; Meriem Khyatti; Sellama Nadifi
Journal:  Lung       Date:  2019-08-29       Impact factor: 2.584

6.  Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation.

Authors:  Yanuar Alan Sulistio; Han Kyu Lee; Sung Jun Jung; Klaus Heese
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

7.  Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane.

Authors:  Andreas Schroers; Oliver Hecht; Karl-Josef Kallen; Michael Pachta; Stefan Rose-John; Joachim Grötzinger
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

Review 8.  IL-6 biology: implications for clinical targeting in rheumatic disease.

Authors:  Leonard H Calabrese; Stefan Rose-John
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

9.  Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma.

Authors:  Verena von Felbert; Francisco Córdoba; Jakob Weissenberger; Claudio Vallan; Masashi Kato; Izumi Nakashima; Lasse Roger Braathen; Joachim Weis
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Neuroprotective properties of ciliary neurotrophic factor for cultured adult rat dorsal root ganglion neurons.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Yukari Komuta; Yang Si; Hitoshi Kawano
Journal:  Histochem Cell Biol       Date:  2008-08-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.